Nanotherapeutics in Cancer

Hardeep Singh Tuli is an assistant professor at the Department of Biotechnology, Maharishi Markandeshwar (Deemed to be University), Mullana, Haryana, India. He has also been a lecturer at the Department of Applied Sciences, Institute of Science and Technology, Klawad, Yamunanagar, India. He has served as a reviewer for several international journals and a guest editor for the journal Frontiers in Pharmacology. He has more than 10 years of teaching and research experience in pharmacology, mammalian physiology, and natural products. Dr. Tuli has published more than 80 papers in peer-reviewed international journals, authored several book chapters, and edited three international books on natural products and chemoprevention. He has been placed in the top 2% of highly cited researchers in the world in the pharmacology area. His research is focused on the isolation, characterization, and biochemical evaluation of natural metabolites as anticancer agents.

• 1. Introduction to Nanotherapeutics: A Synthetic Preview 2. Synthesis, Characterization, and Application of Metal Oxide Nanoparticles 3. Current Scenario of Nanomaterials in Cancer Diagnostics 4. Emerging Antineoplastic Potential of Nanoparticles Against Different Types of Cancer 5. Nanomaterials-Mediated Oxidative Stress in Cancer: Recent Trends and Future Perspectives 6. Role of Nanotherapeutics in Inhibiting Cancer Angiogenesis: A Novel Perspective 7. Inhibition of Cancer Cell Metastasis by Nanotherapeutics: Current Achievements and Future Trends 8. Nanotherapeutics as Potential Carriers for the Delivery of Anticancer Drugs 9. Nanoparticle-Associated Toxicity and Concept of Edible Nanoparticles: Promising Therapeutics in Near Future